Assessing effectiveness of niosomal ketoconazol cream versus niosomal climbazol cream in tinea versicolor patient

Phase 2

Recruiting

• Conditions: Tinea versicolor.; Pityriasis versicolor; B36.0

• Registration Number: IRCT20200725048196N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

A diagnosis of tinea versicolor made by the attending dermatologist who first visit patient at Afzalipour hospitals dermatology clinic
Filling out and signing the written informed consent form by the patient
patients age at least 12 years old
Male or nonpregnant and nonbreastfeeding female

Exclusion Criteria

Any dermatologic or systemic disorders
History of hypersensitivity to ketoconazole or climbazole
Using systemic or topical antifungal drugs or crticosteroides during the 4weeks perior immediatly before starting the trial
Using other antifungal shampoo( selenium sulfide,pyrithione zink)
pregnancy or breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Tinea versicolor lesion severity. Timepoint: At base line and 4,12 weeks later. Method of measurement: severity of lesion( scalling,pruritus,erythema,hyperpigmentation ,hypopigmentation).

Secondary Outcome Measures

Name	Time	Method
Treatment side effect. Timepoint: throughout study periode and up to 3months after the start of the study. Method of measurement: history taking and physical exam.